HDT Bio
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Washington, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1616 Eastlake Ave E Ste 280, Seattle, Wa...Phone Number
(425) 241-4152Website
hdt.bioRevenue
$14.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About HDT Bio
Based out of Seattle, WA, HDT Bio is a biotechnology company with a focus on immunotherapies for oncology and infectious diseases.Explore more
HDT Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is HDT Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if HDT Bio had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
HDT Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if HDT Bio is spiking on competitors!
Funding: Get notified immidiatlly once HDT Bio has new funding data
Congratulate Masked Content for being promoted to Masked Content at HDT Bio
Product Launch: Get notified when HDT Bio launches new products
Check if HDT Bio has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on HDT Bio recently announced quarterly report
Recommended Actions
Find VP level buyers at HDT Bio
Find more new buyers
Compare Similar Companies to HDT Bio
Compare insights from companies similar to HDT Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
HDT Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
HDT Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about HDT Bio.
HDT Bio financials insights
Gather financial insights about HDT Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Angel/Seed
$3M
HDT Bio Tech Stack
A closer look at the technologies used by HDT Bio
See more technologies
Most Recent Scoops
Project
, according to a mid-level source in legal, has completed initiatives related to intellectual property (IP) management within the last twelve months.
Intellectual Property, Legal Affairs
Project
, according to a mid-level source in legal, has completed initiatives related to forensic accounting services within the last twelve months.
Analytics & Insights, Accounting, Financial Reporting, Business Finance, Finance
Project
, according to a mid-level source in legal, has completed initiatives related to security framework within the last twelve months.
IT Audit / Compliance, Information Security, Infrastructure, Product Security, Cyber Security, Security
Project
, according to a mid-level source in legal, has completed initiatives related to risk management and analytics within the last twelve months.
Analytics & Insights, Financial Planning, Finance, Risk
Project
Document Management, Software
HDT Bio News & Media
HDT Bio and UTMB Receive MCDC Innovation Prototype Award for Advancing CCHF Vaccine from Lab to Phase 1 Clinical Trial
SEATTLE, May 21, 2026 /PRNewswire/ -- HDT Bio, a clinical-stage biotechnology company based in Seattle, Washington, today announced that it received the Medical CBRN Defense Consortium (MCDC) Innovation Prototype Award. The award recognizes HDT Bio's MCDC project "Development of...FDA Greenlights HDT Bio's First-in-Class HDT-321 for the Prevention of Deadly Tick-Borne Disease
SEATTLE, Sept. 19, 2025 /PRNewswire/ -- HDT Bio Corporation, a U.S.-based clinical-stage biotechnology company advancing immune-enhancing solutions for global health, biodefense, and oncology, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational...MalarVx licenses HDT Bio's repRNA/LION™ Technology for Novel Malaria Vaccine
HDT Bio's LION™ platform to support malaria vaccine development by MalarVx SEATTLE, Jan. 15, 2025 /PRNewswire/ -- MalarVx, Inc., a clinical-stage vaccine company, is proud to announce a license to HDT Bio's proprietary self-amplifying replicon RNA (repRNA) and lipid nanoparticle (LION™)...HDT Bio to Help Spearhead RNA Vaccine Development in National Pandemic Preparedness Initiative
HDT bio's Rapid-Response Roadmap for RNA vaccines (R4) project granted a five-year subaward for $2M per year SEATTLE, Sept. 17, 2024 /PRNewswire/ -- HDT Bio Corp., a clinical-stage biopharmaceutical company specializing in advanced RNA vaccine technologies, is proud to announce its...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding HDT Bio
Sign Up For FreeTo access detailed company insights
Based out of Seattle, WA, HDT Bio is a biotechnology company with a focus on immunotherapies for oncology and infectious diseases.... Read More
